FDA product code GQL: Antisera, Fluorescent, Herpesvirus Hominis 1,2

GQL is the FDA product code for antisera, fluorescent, herpesvirus hominis 1,2. It is a Class II device, regulated under 21 CFR 866.3305 and reviewed by the Microbiology panel. FDA has cleared 37 510(k) submissions under GQL, from 23 different applicants. The average 510(k) review took 123 days (median 94).

Classification

FieldValue
Device nameAntisera, Fluorescent, Herpesvirus Hominis 1,2
Device classClass II
Regulation21 CFR 866.3305
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

Compare with all 510(k) review times · Search every GQL clearance

Top GQL applicants

ApplicantClearancesLatest
Zeus Scientific, Inc.51999-05-26
Syva Co.41985-03-11
Immulok, Inc.41983-06-30
Ortho Diagnostic Systems, Inc.31989-06-06
Baxter Healthcare Corp21990-07-31

18 more applicants have GQL clearances. See the full list in Caduvo.

Most recent GQL clearances

510(k)ApplicantDeviceDecision dateReview days
K091753Diagnostic Hybrids, Inc.ELVIS HSV ID AND D3 TYPING TEST SYSTEM2009-08-2873
K081527Millipore CorporationLIGHT DIAGNOSTICS HSV 1/2 TYPING DFA KIT2009-04-01303
K984120Zeus Scientific, Inc.THE APTUS(AUTOMATED) APPLICATION OF THE HSV-2 IGG ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR TH1999-05-26189
K984135Zeus Scientific, Inc.THE APTUS (AUTOMATED) APPLICATION OF THE HSV-1 IGG ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR1999-05-26189
K905608Stellar Bio Systems, Inc.INDIRECT FLUORESCENT ASSAY FOR HERPES SIMPLEX 11991-11-07328

Recalls for GQL devices

openFDA lists no recalls for product code GQL.

Frequently asked questions

What is FDA product code GQL?

GQL is the FDA product code for antisera, fluorescent, herpesvirus hominis 1,2. It is a Class II device, regulated under 21 CFR 866.3305 and reviewed by the Microbiology panel.

What device class is GQL?

Class II, regulation 21 CFR 866.3305. Typical premarket route: 510(k).

How long does a 510(k) take for product code GQL?

Across 37 cleared submissions the average was 123 days from receipt to decision (median 94).

Which companies have the most GQL clearances?

Zeus Scientific, Inc. (5); Syva Co. (4); Immulok, Inc. (4); Ortho Diagnostic Systems, Inc. (3); Baxter Healthcare Corp (2).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times